Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antihistamines.

M W Greaves1

  • 1St. John's Institute of Dermatology, St. Thomas' Hospital, London, United Kingdom.

Dermatologic Clinics
|January 13, 2001
PubMed
Summary
This summary is machine-generated.

Third-generation H1 antihistamines offer improved safety and efficacy. Future allergy treatments may focus on non-H1 receptor actions for enhanced antiallergic effects.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pioneers in dermatology and venereology: an interview with Prof. Malcolm Greaves.

Journal of the European Academy of Dermatology and Venereology : JEADV·2018
Same author

Cosmetics and toiletries: evaluation of efficacy, safety and quality.

Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)·2016
Same author

Omalizumab for chronic spontaneous urticaria: a boon for sufferers, but there are unanswered questions.

The British journal of dermatology·2015
Same author

Chronic urticaria due to autoreactivity to progesterone.

Clinical and experimental dermatology·2015
Same author

Chronic urticaria: an orphan disease for 125 years.

The British journal of dermatology·2014
Same author

Unmet clinical needs in chronic spontaneous urticaria. A GA²LEN task force report.

Allergy·2010
Same journal

The Evidence Is In: Devices and Biologics Reshaping Modern Dermatology.

Dermatologic clinics·2026
Same journal

Energy-Based Devices for Body Contouring.

Dermatologic clinics·2026
Same journal

Microfocused Ultrasound with Visualization for Skin Tightening: Clinical Applications, Safety, and Technical Considerations.

Dermatologic clinics·2026
Same journal

Devices in Onychomycosis: A Status Update.

Dermatologic clinics·2026
Same journal

Acne Laser Devices in Dermatology.

Dermatologic clinics·2026
Same journal

Fractional Laser Therapy for Androgenetic Alopecia: Mechanisms, Clinical Evidence, and Practical Implementation.

Dermatologic clinics·2026
See all related articles

Area of Science:

  • Pharmacology
  • Allergy Research

Background:

  • Significant advancements in H1 antihistamine therapeutic index occurred in the 1990s.
  • Third-generation antihistamines exhibit enhanced efficacy and reduced toxicity.

Purpose of the Study:

  • To review the progress in H1 antihistamine development.
  • To explore future directions in antiallergic drug discovery.

Main Methods:

  • Literature review of pharmacological advancements.
  • Analysis of therapeutic index improvements and non-H1 receptor mechanisms.

Main Results:

  • Third-generation antihistamines represent a major therapeutic improvement.
  • Non-H1 receptor-mediated actions are identified as a key area for future development.

Conclusions:

  • Future breakthroughs in allergy treatment will likely stem from targeting non-H1 receptor pathways.
  • Exploiting novel mechanisms beyond H1 receptor antagonism is crucial for next-generation antiallergic therapies.